Winslow Evans & Crocker’s DexCom DXCM Stock Holding History

Winslow Evans & Crocker’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$6K	Hold	60	–	–	﹤0.01%	1036
2020 Q3	$6K	Sell	60 -1,900	-97%	-$199K	﹤0.01%	833
2020 Q2	$199K	Buy	1,960 +1,896	+2,963%	+$170K	0.05%	272
2020 Q1	$6K	Hold	64	–	–	﹤0.01%	803
2019 Q4	$4K	Hold	64	–	–	﹤0.01%	985
2019 Q3	$4K	Hold	64	–	–	﹤0.01%	977
2019 Q2	$4K	Hold	64	–	–	﹤0.01%	992
2019 Q1	$2K	Buy	+64	New	+$2.25K	﹤0.01%	1135

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Winslow Evans & Crocker's DXCM Position: Q4 2020 in Review

Winslow Evans & Crocker held its DexCom (DXCM) position steady in Q4 2020 at 60 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1036.

Winslow Evans & Crocker first reported a position in DXCM in Q1 2019 and has held it in 8 quarters since. The position peaked at $199K in Q2 2020. 732 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

Winslow Evans & Crocker held 60 shares of DexCom worth $6K as of Q4 2020.
Winslow Evans & Crocker left its DexCom share count unchanged in Q4 2020.
DexCom made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1036 holding.
Winslow Evans & Crocker first reported a position in DexCom in Q1 2019 and has held it in 8 quarters since.
Winslow Evans & Crocker's DexCom position peaked at $199K in Q2 2020.
732 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.